2.85
-0.01 (-0.35%)
-0.01 (-0.35%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
Big Cap Pro
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Acer Therapeutics Inc | ACER | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
-0.01 | -0.35% | 2.85 | 20:00:00 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.83 | 2.80 | 3.02 | 2.87 | 2.86 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
2.75 | 2.97 | 0.22 | - | - |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,145 | 305,706 | $ 2.91 | $ 890,937 | 1,428,459 | 1.35 - 7.05 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:56:54 | 10 | $ 2.91 | USD |
Acer Therapeutics Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 39.67M | 13.92M | 9.12M | $ - | $ - | -2.91 | -1.80 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | - | - |
Acer Therapeutics News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACER Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.09 | 3.1699 | 2.80 | 2.96 | 287,442 | -0.24 | -7.77% |
1 Month | 3.52 | 4.40 | 2.80 | 3.57 | 776,034 | -0.67 | -19.03% |
3 Months | 4.23 | 5.39 | 2.50 | 3.87 | 952,177 | -1.38 | -32.62% |
6 Months | 2.91 | 5.39 | 2.30 | 3.71 | 778,038 | -0.06 | -2.06% |
1 Year | 2.07 | 7.05 | 1.35 | 3.70 | 540,803 | 0.78 | 37.68% |
3 Years | 19.48 | 34.10 | 1.08 | 4.94 | 238,980 | -16.63 | -85.37% |
5 Years | 8.55 | 34.10 | 1.08 | 5.18 | 205,851 | -5.70 | -66.67% |
Acer Therapeutics Description
Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease. |